science
U.S. Health-Care Spending Reached $5.7 Trillion in 2025
Government figures show a 7.3% rise from 2024, with per-person costs near $16,500 and prescription drug outlays up more than 11%. The FDA also cleared two new first-line treatments for advanced triple-negative breast cancer within a month.
news.gallup.comAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
U.S. health-care spending reached $5.7 trillion in 2025, a 7.3% increase from the prior year, according to figures published in Health Affairs. The total averaged almost $16,500 per person. Stat reported that Americans visited doctors, underwent hospital procedures, and filled prescriptions more often than forecasters had expected.
Prescription-drug spending rose more than 11% during the year, federal officials said. Weight-loss medicines contributed to the faster pace of outlays. The FDA approved Gilead Sciences’ Trodelvy as a first-line treatment for newly diagnosed patients with advanced triple-negative breast cancer.
The decision marked the second such approval in roughly a month. AstraZeneca and Daiichi Sankyo’s Datroway received clearance for a similar patient group in May. Stat noted that drugmakers have developed additional options for this aggressive form of the disease after years with limited progress.
Transparency
How sources framed this
Single source — no framing comparison available.
CorroborationModerate · 1 source
